The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
06/01/26: Fellow Exam Application Deadline
Learn more
06/01/26: Research Grant Cycle
Learn more
08/08/26: Scientific Abstract Submission Deadline
Learn more
12/01/26: Research Grant Cycle
Learn more
You can now access 19.75 hrs of CME | Continuing Certification (CC) until March 23 by watching recorded content from the AAOA Explorers Course 2026! Watch lectures at your pace and leisure while traveling or in the comfort of your home or office. You have over two and a half months to watch everything and maybe re-watch some of the lectures! Learn More
We are pleased to invite you to participate in the 2026 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2026 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2026:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
Content Access Until March 23, 2026
Learn More and Register
2026 AAOA Basic Course in Allergy & Immunology – Hybrid
90-days Access June 9– Sep 14, 2026
July 9-11, 2026 – Live
The Diplomat, Hollywood, Florida
Learn More and Register
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available February 1 - April 30, 2026
AAOA is proud to announce its new Affinity Program with US ENT, a group purchasing…
“But time, keeps flowing like a river….on and on to the sea” Alan Parsons Project…
Keith Sale, MD, AAOA President-Elect, recently testified before the Senate Subcommittee hearing, Avoiding a Cautionary Tale: Policy…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee Schedule (PFS) detailing policies related to Medicare physician payment and the Quality Payment Program (QPP). A brief summary of key provisions for AAOA members follows:…
You have allergy symptoms, and want to find something to treat your symptoms without having to go to a doctor. The allergy aisle in the pharmacy or big box store is overwhelming. What do all these drugs do? Let's break…
The Food and Drug Administration (FDA) states, in a revised draft guidance released this week, that it does not intend to enforce the “insanitary conditions” provision of the Food, Drug and Cosmetic Act against physicians that compound or mix in their…
The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its sponsoring organization, the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American Academy of Otolaryngic Allergy (AAOA) submitted comments on the proposed changes…
FDA has a drug shortage database which includes reasons for and updates on drug shortages. Today the database read, “Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen® and the authorized generic version, continues to experience manufacturing constraints. Currently, supplies will vary from…
The Food and Drug Administration approves the first generic version of EpiPen and EpiPen Jr. FDA Commissioner Scott Gottlieb, M.D states that “This approval means patients living with severe allergies who require constant access to life-saving epinephrine should have a…
This year’s Annual Meeting assures to be not only educational, interactive, and practice-centered, but also fun! We offer several networking and social events for you to meet new people, learn from peers and just enjoy your time in Philadelphia! You…
August 22 - Extended Hotel Discounted Rate Deadline Room Rate Room rate is $219 (plus 15.5% tax) single/double occupancy. At check in, each guest will have the opportunity to reconfirm departure date. Guests departing prior to that date will be assessed a…
An updated draft of USP Chapter 797 was released today. Updated Chapter 797 Posted for Public Comment: Separate Requirements for In-office Compounding of Allergen Extract Restored In September 2015, the United States Pharmacopeia (USP) released a proposed updated Chapter 797 on procedures for sterile compounding. The existing chapter had provided procedures for allergen immunotherapy extracts…
The second year of the Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA) began in January, but in February, Congress responded to concerns from the physician community and made changes to the Merit-Based Incentive…